Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saul Genuth

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The New England Journal of Medicine|July 1, 2010
Effects of medical therapies on retinopathy progression in type 2 diabetes, , Emily Y Chew, et al.
BMJ (Clinical Research Ed.)|January 12, 2010
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD studyMichael E Miller, Denise E Bonds, Hertzel C Gerstein, et al.
Lancet (London, England)|July 3, 2010
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trialFaramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The New England Journal of Medicine|July 1, 2010
Effects of medical therapies on retinopathy progression in type 2 diabetes, , Emily Y Chew, et al.
BMJ (Clinical Research Ed.)|January 12, 2010
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD studyMichael E Miller, Denise E Bonds, Hertzel C Gerstein, et al.
Lancet (London, England)|July 3, 2010
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trialFaramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, et al.
Pageof 6